Literature DB >> 4182181

Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia.

C J Glueck, W V Brown, R I Levy, H Greten, D S Fredrickson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4182181     DOI： 10.1016/s0140-6736(69)92225-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Indications for lipid-lowering drugs.

Authors:  J Davignon
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Progestagens, anabolic-androgenic compounds, estrogens: effects on triglycerides and postheparin lipolytic enzymes.

Authors:  C J Glueck; D Scheel; J Fishback; P Steiner
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

3.  Hormones and lipid metabolism.

Authors: 
Journal:  Postgrad Med J       Date:  1972-10       Impact factor: 2.401

4.  Case reports. Hyperlipaemic pancreatitis and the pill.

Authors:  S Bank; I N Marks
Journal:  Postgrad Med J       Date:  1970-09       Impact factor: 2.401

Review 5.  Lipids and the pill.

Authors:  R B Alfin-Slater; L Aftergood
Journal:  Lipids       Date:  1971-10       Impact factor: 1.880

6.  Sex steroid influence on triglyceride metabolism.

Authors:  H J Kim; R K Kalkhoff
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

7.  Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver.

Authors:  R K Ockner; N Lysenko; J A Manning; S E Monroe; D A Burnett
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.